nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Carmustine—malignant glioma	0.124	0.569	CbGbCtD
Bromocriptine—CYP3A4—Temozolomide—malignant glioma	0.0938	0.43	CbGbCtD
Bromocriptine—Neoplasm recurrence—Carmustine—malignant glioma	0.0817	0.246	CcSEcCtD
Bromocriptine—Cerebrospinal fluid leakage—Carmustine—malignant glioma	0.0817	0.246	CcSEcCtD
Bromocriptine—HTR1D—meninx—malignant glioma	0.0263	0.0905	CbGeAlD
Bromocriptine—HTR1B—dura mater—malignant glioma	0.025	0.086	CbGeAlD
Bromocriptine—HTR1D—dura mater—malignant glioma	0.0242	0.0832	CbGeAlD
Bromocriptine—HTR2C—choroid plexus—malignant glioma	0.0204	0.0701	CbGeAlD
Bromocriptine—Status epilepticus—Temozolomide—malignant glioma	0.0116	0.0349	CcSEcCtD
Bromocriptine—DRD3—telencephalic ventricle—malignant glioma	0.0107	0.0369	CbGeAlD
Bromocriptine—HTR2A—choroid plexus—malignant glioma	0.0102	0.0352	CbGeAlD
Bromocriptine—Fibrosis—Carmustine—malignant glioma	0.00989	0.0298	CcSEcCtD
Bromocriptine—Vasospasm—Carmustine—malignant glioma	0.00828	0.0249	CcSEcCtD
Bromocriptine—DRD1—telencephalic ventricle—malignant glioma	0.00769	0.0264	CbGeAlD
Bromocriptine—Pulmonary fibrosis—Carmustine—malignant glioma	0.00643	0.0194	CcSEcCtD
Bromocriptine—HTR1B—telencephalic ventricle—malignant glioma	0.00623	0.0214	CbGeAlD
Bromocriptine—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00621	0.0187	CcSEcCtD
Bromocriptine—HTR1D—telencephalic ventricle—malignant glioma	0.00603	0.0207	CbGeAlD
Bromocriptine—Lung infiltration—Carmustine—malignant glioma	0.00603	0.0182	CcSEcCtD
Bromocriptine—HTR2C—telencephalic ventricle—malignant glioma	0.00597	0.0205	CbGeAlD
Bromocriptine—HTR7—pons—malignant glioma	0.00584	0.0201	CbGeAlD
Bromocriptine—HTR2A—cerebellar cortex—malignant glioma	0.00515	0.0177	CbGeAlD
Bromocriptine—HTR1A—telencephalic ventricle—malignant glioma	0.00503	0.0173	CbGeAlD
Bromocriptine—HTR7—telencephalic ventricle—malignant glioma	0.00481	0.0165	CbGeAlD
Bromocriptine—DRD2—telencephalic ventricle—malignant glioma	0.00454	0.0156	CbGeAlD
Bromocriptine—Paranoia—Carmustine—malignant glioma	0.00415	0.0125	CcSEcCtD
Bromocriptine—Burning sensation—Carmustine—malignant glioma	0.00407	0.0123	CcSEcCtD
Bromocriptine—HTR2A—pons—malignant glioma	0.00364	0.0125	CbGeAlD
Bromocriptine—HTR2A—vertebral column—malignant glioma	0.00361	0.0124	CbGeAlD
Bromocriptine—HTR1B—blood vessel—malignant glioma	0.00308	0.0106	CbGeAlD
Bromocriptine—HTR2A—telencephalic ventricle—malignant glioma	0.003	0.0103	CbGeAlD
Bromocriptine—HTR1D—blood vessel—malignant glioma	0.00299	0.0103	CbGeAlD
Bromocriptine—Urinary incontinence—Carmustine—malignant glioma	0.00273	0.00822	CcSEcCtD
Bromocriptine—Urinary incontinence—Temozolomide—malignant glioma	0.00264	0.00794	CcSEcCtD
Bromocriptine—HTR2A—pineal body—malignant glioma	0.0026	0.00894	CbGeAlD
Bromocriptine—HTR7—endothelium—malignant glioma	0.00258	0.00887	CbGeAlD
Bromocriptine—HTR6—telencephalon—malignant glioma	0.00248	0.00853	CbGeAlD
Bromocriptine—DRD5—telencephalon—malignant glioma	0.00242	0.00831	CbGeAlD
Bromocriptine—HTR7—blood vessel—malignant glioma	0.00238	0.00818	CbGeAlD
Bromocriptine—Diabetes mellitus—Carmustine—malignant glioma	0.00236	0.00711	CcSEcCtD
Bromocriptine—Nasal congestion—Temozolomide—malignant glioma	0.00218	0.00656	CcSEcCtD
Bromocriptine—DRD1—brainstem—malignant glioma	0.00208	0.00715	CbGeAlD
Bromocriptine—Diplopia—Carmustine—malignant glioma	0.00205	0.00618	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00205	0.00618	CcSEcCtD
Bromocriptine—Diplopia—Temozolomide—malignant glioma	0.00198	0.00597	CcSEcCtD
Bromocriptine—ADRA1D—telencephalon—malignant glioma	0.00194	0.00666	CbGeAlD
Bromocriptine—Ataxia—Carmustine—malignant glioma	0.00193	0.00581	CcSEcCtD
Bromocriptine—Ataxia—Temozolomide—malignant glioma	0.00186	0.00562	CcSEcCtD
Bromocriptine—DRD1—telencephalon—malignant glioma	0.00185	0.00635	CbGeAlD
Bromocriptine—Dysphagia—Carmustine—malignant glioma	0.00177	0.00534	CcSEcCtD
Bromocriptine—Dysphagia—Temozolomide—malignant glioma	0.00171	0.00516	CcSEcCtD
Bromocriptine—HTR1B—brainstem—malignant glioma	0.00169	0.0058	CbGeAlD
Bromocriptine—DRD4—brain—malignant glioma	0.00166	0.00569	CbGeAlD
Bromocriptine—HTR1D—brainstem—malignant glioma	0.00163	0.00561	CbGeAlD
Bromocriptine—HTR2C—brainstem—malignant glioma	0.00162	0.00556	CbGeAlD
Bromocriptine—HTR2A—endothelium—malignant glioma	0.00161	0.00553	CbGeAlD
Bromocriptine—Pollakiuria—Temozolomide—malignant glioma	0.00158	0.00477	CcSEcCtD
Bromocriptine—HTR1B—telencephalon—malignant glioma	0.0015	0.00514	CbGeAlD
Bromocriptine—HTR2A—blood vessel—malignant glioma	0.00148	0.0051	CbGeAlD
Bromocriptine—DRD3—central nervous system—malignant glioma	0.00147	0.00504	CbGeAlD
Bromocriptine—HTR1D—telencephalon—malignant glioma	0.00145	0.00498	CbGeAlD
Bromocriptine—HTR2C—telencephalon—malignant glioma	0.00143	0.00493	CbGeAlD
Bromocriptine—Sinusitis—Temozolomide—malignant glioma	0.00143	0.00432	CcSEcCtD
Bromocriptine—Hypoaesthesia—Carmustine—malignant glioma	0.00141	0.00425	CcSEcCtD
Bromocriptine—Hallucination—Carmustine—malignant glioma	0.00141	0.00425	CcSEcCtD
Bromocriptine—HTR6—central nervous system—malignant glioma	0.00141	0.00485	CbGeAlD
Bromocriptine—ADRB1—telencephalon—malignant glioma	0.00141	0.00484	CbGeAlD
Bromocriptine—Oedema peripheral—Carmustine—malignant glioma	0.0014	0.00421	CcSEcCtD
Bromocriptine—Connective tissue disorder—Carmustine—malignant glioma	0.0014	0.0042	CcSEcCtD
Bromocriptine—DRD5—central nervous system—malignant glioma	0.00137	0.00472	CbGeAlD
Bromocriptine—Visual impairment—Carmustine—malignant glioma	0.00137	0.00412	CcSEcCtD
Bromocriptine—Hypoaesthesia—Temozolomide—malignant glioma	0.00137	0.00411	CcSEcCtD
Bromocriptine—Hallucination—Temozolomide—malignant glioma	0.00137	0.00411	CcSEcCtD
Bromocriptine—HTR1A—brainstem—malignant glioma	0.00136	0.00468	CbGeAlD
Bromocriptine—Oedema peripheral—Temozolomide—malignant glioma	0.00135	0.00407	CcSEcCtD
Bromocriptine—Connective tissue disorder—Temozolomide—malignant glioma	0.00135	0.00406	CcSEcCtD
Bromocriptine—HTR2B—telencephalon—malignant glioma	0.00135	0.00463	CbGeAlD
Bromocriptine—Eye disorder—Carmustine—malignant glioma	0.00133	0.004	CcSEcCtD
Bromocriptine—DRD1—midbrain—malignant glioma	0.00133	0.00456	CbGeAlD
Bromocriptine—Visual impairment—Temozolomide—malignant glioma	0.00132	0.00398	CcSEcCtD
Bromocriptine—HTR7—brainstem—malignant glioma	0.0013	0.00447	CbGeAlD
Bromocriptine—Eye disorder—Temozolomide—malignant glioma	0.00128	0.00386	CcSEcCtD
Bromocriptine—Tinnitus—Temozolomide—malignant glioma	0.00128	0.00385	CcSEcCtD
Bromocriptine—Cardiac disorder—Temozolomide—malignant glioma	0.00127	0.00383	CcSEcCtD
Bromocriptine—Arrhythmia—Carmustine—malignant glioma	0.00127	0.00382	CcSEcCtD
Bromocriptine—Alopecia—Carmustine—malignant glioma	0.00125	0.00378	CcSEcCtD
Bromocriptine—ADRA1A—brainstem—malignant glioma	0.00125	0.00431	CbGeAlD
Bromocriptine—Angiopathy—Temozolomide—malignant glioma	0.00124	0.00375	CcSEcCtD
Bromocriptine—Mental disorder—Carmustine—malignant glioma	0.00124	0.00375	CcSEcCtD
Bromocriptine—Mediastinal disorder—Temozolomide—malignant glioma	0.00124	0.00372	CcSEcCtD
Bromocriptine—DRD2—brainstem—malignant glioma	0.00123	0.00423	CbGeAlD
Bromocriptine—Alopecia—Temozolomide—malignant glioma	0.00121	0.00365	CcSEcCtD
Bromocriptine—HTR1A—telencephalon—malignant glioma	0.00121	0.00415	CbGeAlD
Bromocriptine—Mental disorder—Temozolomide—malignant glioma	0.0012	0.00362	CcSEcCtD
Bromocriptine—DRD2—retina—malignant glioma	0.00119	0.00408	CbGeAlD
Bromocriptine—Dysgeusia—Temozolomide—malignant glioma	0.00117	0.00352	CcSEcCtD
Bromocriptine—Vision blurred—Carmustine—malignant glioma	0.00116	0.00351	CcSEcCtD
Bromocriptine—DRD3—brain—malignant glioma	0.00116	0.004	CbGeAlD
Bromocriptine—HTR7—telencephalon—malignant glioma	0.00115	0.00397	CbGeAlD
Bromocriptine—Agitation—Carmustine—malignant glioma	0.00114	0.00342	CcSEcCtD
Bromocriptine—HTR2C—medulla oblongata—malignant glioma	0.00113	0.00387	CbGeAlD
Bromocriptine—ADRA1B—central nervous system—malignant glioma	0.00113	0.00387	CbGeAlD
Bromocriptine—Vision blurred—Temozolomide—malignant glioma	0.00113	0.00339	CcSEcCtD
Bromocriptine—HTR6—brain—malignant glioma	0.00112	0.00385	CbGeAlD
Bromocriptine—ADRA1A—telencephalon—malignant glioma	0.00111	0.00383	CbGeAlD
Bromocriptine—ADRA1D—central nervous system—malignant glioma	0.0011	0.00379	CbGeAlD
Bromocriptine—Agitation—Temozolomide—malignant glioma	0.0011	0.00331	CcSEcCtD
Bromocriptine—DRD2—telencephalon—malignant glioma	0.00109	0.00375	CbGeAlD
Bromocriptine—DRD5—brain—malignant glioma	0.00109	0.00375	CbGeAlD
Bromocriptine—HTR1B—midbrain—malignant glioma	0.00107	0.00369	CbGeAlD
Bromocriptine—Vertigo—Temozolomide—malignant glioma	0.00107	0.00323	CcSEcCtD
Bromocriptine—Convulsion—Carmustine—malignant glioma	0.00107	0.00322	CcSEcCtD
Bromocriptine—Hypertension—Carmustine—malignant glioma	0.00107	0.00321	CcSEcCtD
Bromocriptine—ADRA2C—telencephalon—malignant glioma	0.00106	0.00365	CbGeAlD
Bromocriptine—DRD1—central nervous system—malignant glioma	0.00105	0.00361	CbGeAlD
Bromocriptine—Anxiety—Carmustine—malignant glioma	0.00105	0.00316	CcSEcCtD
Bromocriptine—HTR1B—spinal cord—malignant glioma	0.00105	0.0036	CbGeAlD
Bromocriptine—HTR1D—midbrain—malignant glioma	0.00104	0.00358	CbGeAlD
Bromocriptine—Convulsion—Temozolomide—malignant glioma	0.00103	0.00312	CcSEcCtD
Bromocriptine—Hypertension—Temozolomide—malignant glioma	0.00103	0.00311	CcSEcCtD
Bromocriptine—HTR2C—midbrain—malignant glioma	0.00103	0.00354	CbGeAlD
Bromocriptine—Confusional state—Carmustine—malignant glioma	0.00102	0.00306	CcSEcCtD
Bromocriptine—Anxiety—Temozolomide—malignant glioma	0.00101	0.00305	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00101	0.00304	CcSEcCtD
Bromocriptine—Oedema—Carmustine—malignant glioma	0.00101	0.00304	CcSEcCtD
Bromocriptine—HTR2C—spinal cord—malignant glioma	0.00101	0.00345	CbGeAlD
Bromocriptine—Infection—Carmustine—malignant glioma	0.001	0.00302	CcSEcCtD
Bromocriptine—Dry mouth—Temozolomide—malignant glioma	0.000994	0.00299	CcSEcCtD
Bromocriptine—Tachycardia—Carmustine—malignant glioma	0.000984	0.00296	CcSEcCtD
Bromocriptine—Confusional state—Temozolomide—malignant glioma	0.000983	0.00296	CcSEcCtD
Bromocriptine—Oedema—Temozolomide—malignant glioma	0.000975	0.00294	CcSEcCtD
Bromocriptine—ABCB1—blood vessel—malignant glioma	0.000972	0.00334	CbGeAlD
Bromocriptine—Infection—Temozolomide—malignant glioma	0.000968	0.00292	CcSEcCtD
Bromocriptine—Anorexia—Carmustine—malignant glioma	0.000961	0.0029	CcSEcCtD
Bromocriptine—Nervous system disorder—Temozolomide—malignant glioma	0.000956	0.00288	CcSEcCtD
Bromocriptine—Skin disorder—Temozolomide—malignant glioma	0.000947	0.00285	CcSEcCtD
Bromocriptine—Hypotension—Carmustine—malignant glioma	0.000943	0.00284	CcSEcCtD
Bromocriptine—Anorexia—Temozolomide—malignant glioma	0.000929	0.0028	CcSEcCtD
Bromocriptine—Insomnia—Carmustine—malignant glioma	0.000912	0.00275	CcSEcCtD
Bromocriptine—HTR7—medulla oblongata—malignant glioma	0.000907	0.00312	CbGeAlD
Bromocriptine—Paraesthesia—Carmustine—malignant glioma	0.000906	0.00273	CcSEcCtD
Bromocriptine—Dyspnoea—Carmustine—malignant glioma	0.000899	0.00271	CcSEcCtD
Bromocriptine—Somnolence—Carmustine—malignant glioma	0.000897	0.0027	CcSEcCtD
Bromocriptine—ADRA1B—brain—malignant glioma	0.000894	0.00307	CbGeAlD
Bromocriptine—HTR2A—embryo—malignant glioma	0.000885	0.00304	CbGeAlD
Bromocriptine—Insomnia—Temozolomide—malignant glioma	0.000882	0.00265	CcSEcCtD
Bromocriptine—Decreased appetite—Carmustine—malignant glioma	0.000877	0.00264	CcSEcCtD
Bromocriptine—Paraesthesia—Temozolomide—malignant glioma	0.000875	0.00264	CcSEcCtD
Bromocriptine—ADRA1D—brain—malignant glioma	0.000874	0.00301	CbGeAlD
Bromocriptine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000871	0.00262	CcSEcCtD
Bromocriptine—Dyspnoea—Temozolomide—malignant glioma	0.000869	0.00262	CcSEcCtD
Bromocriptine—HTR1A—midbrain—malignant glioma	0.000867	0.00298	CbGeAlD
Bromocriptine—Somnolence—Temozolomide—malignant glioma	0.000867	0.00261	CcSEcCtD
Bromocriptine—Constipation—Carmustine—malignant glioma	0.000863	0.0026	CcSEcCtD
Bromocriptine—Dyspepsia—Temozolomide—malignant glioma	0.000858	0.00258	CcSEcCtD
Bromocriptine—HTR1B—central nervous system—malignant glioma	0.00085	0.00292	CbGeAlD
Bromocriptine—Decreased appetite—Temozolomide—malignant glioma	0.000847	0.00255	CcSEcCtD
Bromocriptine—ADRA2A—telencephalon—malignant glioma	0.000846	0.00291	CbGeAlD
Bromocriptine—HTR1A—spinal cord—malignant glioma	0.000846	0.00291	CbGeAlD
Bromocriptine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000842	0.00253	CcSEcCtD
Bromocriptine—Fatigue—Temozolomide—malignant glioma	0.00084	0.00253	CcSEcCtD
Bromocriptine—Constipation—Temozolomide—malignant glioma	0.000834	0.00251	CcSEcCtD
Bromocriptine—ADRA2C—medulla oblongata—malignant glioma	0.000833	0.00286	CbGeAlD
Bromocriptine—DRD1—brain—malignant glioma	0.000833	0.00286	CbGeAlD
Bromocriptine—Feeling abnormal—Carmustine—malignant glioma	0.000831	0.0025	CcSEcCtD
Bromocriptine—HTR7—midbrain—malignant glioma	0.000829	0.00285	CbGeAlD
Bromocriptine—Gastrointestinal pain—Carmustine—malignant glioma	0.000825	0.00248	CcSEcCtD
Bromocriptine—HTR1D—central nervous system—malignant glioma	0.000823	0.00283	CbGeAlD
Bromocriptine—HTR2C—central nervous system—malignant glioma	0.000815	0.0028	CbGeAlD
Bromocriptine—HTR2A—brainstem—malignant glioma	0.000811	0.00279	CbGeAlD
Bromocriptine—HTR7—spinal cord—malignant glioma	0.000808	0.00278	CbGeAlD
Bromocriptine—Feeling abnormal—Temozolomide—malignant glioma	0.000803	0.00242	CcSEcCtD
Bromocriptine—ADRB1—central nervous system—malignant glioma	0.0008	0.00275	CbGeAlD
Bromocriptine—Abdominal pain—Carmustine—malignant glioma	0.000797	0.0024	CcSEcCtD
Bromocriptine—Body temperature increased—Carmustine—malignant glioma	0.000797	0.0024	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000797	0.0024	CcSEcCtD
Bromocriptine—DRD2—midbrain—malignant glioma	0.000783	0.00269	CbGeAlD
Bromocriptine—HTR2A—retina—malignant glioma	0.000782	0.00269	CbGeAlD
Bromocriptine—Urticaria—Temozolomide—malignant glioma	0.000774	0.00233	CcSEcCtD
Bromocriptine—Abdominal pain—Temozolomide—malignant glioma	0.000771	0.00232	CcSEcCtD
Bromocriptine—Body temperature increased—Temozolomide—malignant glioma	0.000771	0.00232	CcSEcCtD
Bromocriptine—HTR2B—central nervous system—malignant glioma	0.000766	0.00263	CbGeAlD
Bromocriptine—ADRA2C—midbrain—malignant glioma	0.000762	0.00262	CbGeAlD
Bromocriptine—ADRA2C—spinal cord—malignant glioma	0.000743	0.00255	CbGeAlD
Bromocriptine—Asthenia—Carmustine—malignant glioma	0.000724	0.00218	CcSEcCtD
Bromocriptine—HTR2A—telencephalon—malignant glioma	0.00072	0.00247	CbGeAlD
Bromocriptine—Asthenia—Temozolomide—malignant glioma	0.000699	0.00211	CcSEcCtD
Bromocriptine—Diarrhoea—Carmustine—malignant glioma	0.00069	0.00208	CcSEcCtD
Bromocriptine—HTR1A—central nervous system—malignant glioma	0.000686	0.00236	CbGeAlD
Bromocriptine—HTR1B—brain—malignant glioma	0.000675	0.00232	CbGeAlD
Bromocriptine—HTR1A—cerebellum—malignant glioma	0.000671	0.00231	CbGeAlD
Bromocriptine—Dizziness—Carmustine—malignant glioma	0.000667	0.00201	CcSEcCtD
Bromocriptine—Diarrhoea—Temozolomide—malignant glioma	0.000667	0.00201	CcSEcCtD
Bromocriptine—ADRA2A—medulla oblongata—malignant glioma	0.000665	0.00229	CbGeAlD
Bromocriptine—HTR7—central nervous system—malignant glioma	0.000656	0.00225	CbGeAlD
Bromocriptine—HTR1D—brain—malignant glioma	0.000654	0.00225	CbGeAlD
Bromocriptine—HTR2C—brain—malignant glioma	0.000647	0.00223	CbGeAlD
Bromocriptine—Dizziness—Temozolomide—malignant glioma	0.000645	0.00194	CcSEcCtD
Bromocriptine—Vomiting—Carmustine—malignant glioma	0.000641	0.00193	CcSEcCtD
Bromocriptine—HTR7—cerebellum—malignant glioma	0.000641	0.0022	CbGeAlD
Bromocriptine—Rash—Carmustine—malignant glioma	0.000636	0.00192	CcSEcCtD
Bromocriptine—Dermatitis—Carmustine—malignant glioma	0.000635	0.00191	CcSEcCtD
Bromocriptine—ADRB1—brain—malignant glioma	0.000635	0.00218	CbGeAlD
Bromocriptine—ADRA1A—central nervous system—malignant glioma	0.000633	0.00217	CbGeAlD
Bromocriptine—Headache—Carmustine—malignant glioma	0.000632	0.0019	CcSEcCtD
Bromocriptine—DRD2—central nervous system—malignant glioma	0.00062	0.00213	CbGeAlD
Bromocriptine—Vomiting—Temozolomide—malignant glioma	0.00062	0.00187	CcSEcCtD
Bromocriptine—ADRA1A—cerebellum—malignant glioma	0.000618	0.00213	CbGeAlD
Bromocriptine—Rash—Temozolomide—malignant glioma	0.000615	0.00185	CcSEcCtD
Bromocriptine—Dermatitis—Temozolomide—malignant glioma	0.000614	0.00185	CcSEcCtD
Bromocriptine—Headache—Temozolomide—malignant glioma	0.000611	0.00184	CcSEcCtD
Bromocriptine—HTR2B—brain—malignant glioma	0.000608	0.00209	CbGeAlD
Bromocriptine—ADRA2A—midbrain—malignant glioma	0.000608	0.00209	CbGeAlD
Bromocriptine—DRD2—cerebellum—malignant glioma	0.000606	0.00208	CbGeAlD
Bromocriptine—ADRA2C—central nervous system—malignant glioma	0.000603	0.00207	CbGeAlD
Bromocriptine—Nausea—Carmustine—malignant glioma	0.000599	0.0018	CcSEcCtD
Bromocriptine—ADRA2A—spinal cord—malignant glioma	0.000593	0.00204	CbGeAlD
Bromocriptine—ADRA2C—cerebellum—malignant glioma	0.000589	0.00203	CbGeAlD
Bromocriptine—ABCB1—embryo—malignant glioma	0.00058	0.00199	CbGeAlD
Bromocriptine—Nausea—Temozolomide—malignant glioma	0.000579	0.00174	CcSEcCtD
Bromocriptine—HTR2A—medulla oblongata—malignant glioma	0.000565	0.00194	CbGeAlD
Bromocriptine—HTR1A—brain—malignant glioma	0.000545	0.00187	CbGeAlD
Bromocriptine—HTR7—brain—malignant glioma	0.000521	0.00179	CbGeAlD
Bromocriptine—HTR2A—midbrain—malignant glioma	0.000517	0.00178	CbGeAlD
Bromocriptine—ABCB1—retina—malignant glioma	0.000513	0.00176	CbGeAlD
Bromocriptine—HTR2A—spinal cord—malignant glioma	0.000504	0.00173	CbGeAlD
Bromocriptine—ADRA1A—brain—malignant glioma	0.000502	0.00173	CbGeAlD
Bromocriptine—DRD2—brain—malignant glioma	0.000492	0.00169	CbGeAlD
Bromocriptine—ADRA2A—central nervous system—malignant glioma	0.000481	0.00165	CbGeAlD
Bromocriptine—ADRA2C—brain—malignant glioma	0.000479	0.00165	CbGeAlD
Bromocriptine—ABCB1—telencephalon—malignant glioma	0.000472	0.00162	CbGeAlD
Bromocriptine—ADRA2A—cerebellum—malignant glioma	0.00047	0.00162	CbGeAlD
Bromocriptine—HTR2A—central nervous system—malignant glioma	0.000409	0.00141	CbGeAlD
Bromocriptine—HTR2A—cerebellum—malignant glioma	0.0004	0.00137	CbGeAlD
Bromocriptine—ADRA2A—brain—malignant glioma	0.000382	0.00131	CbGeAlD
Bromocriptine—CYP3A4—central nervous system—malignant glioma	0.000379	0.0013	CbGeAlD
Bromocriptine—ABCB1—medulla oblongata—malignant glioma	0.00037	0.00127	CbGeAlD
Bromocriptine—ABCB1—midbrain—malignant glioma	0.000339	0.00116	CbGeAlD
Bromocriptine—ABCB1—spinal cord—malignant glioma	0.00033	0.00114	CbGeAlD
Bromocriptine—HTR2A—brain—malignant glioma	0.000325	0.00112	CbGeAlD
Bromocriptine—ABCB1—central nervous system—malignant glioma	0.000268	0.000921	CbGeAlD
Bromocriptine—ABCB1—cerebellum—malignant glioma	0.000262	0.000901	CbGeAlD
Bromocriptine—ABCB1—brain—malignant glioma	0.000213	0.000731	CbGeAlD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—malignant glioma	9.62e-06	6.05e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CASP3—malignant glioma	9.6e-06	6.03e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2—malignant glioma	9.58e-06	6.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	9.55e-06	6e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CASP3—malignant glioma	9.55e-06	6e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2—malignant glioma	9.53e-06	5.99e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NCOR1—malignant glioma	9.52e-06	5.98e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—malignant glioma	9.48e-06	5.96e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—malignant glioma	9.47e-06	5.95e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—malignant glioma	9.47e-06	5.95e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	9.46e-06	5.94e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PTEN—malignant glioma	9.43e-06	5.93e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MDM2—malignant glioma	9.42e-06	5.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	9.41e-06	5.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—malignant glioma	9.4e-06	5.91e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RAF1—malignant glioma	9.38e-06	5.9e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—STAT3—malignant glioma	9.38e-06	5.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	9.37e-06	5.89e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—KRAS—malignant glioma	9.35e-06	5.88e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	9.35e-06	5.87e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—malignant glioma	9.35e-06	5.87e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—KRAS—malignant glioma	9.34e-06	5.87e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PTEN—malignant glioma	9.34e-06	5.87e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	9.32e-06	5.86e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	9.3e-06	5.85e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CASP3—malignant glioma	9.29e-06	5.84e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ERBB2—malignant glioma	9.28e-06	5.84e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—KRAS—malignant glioma	9.28e-06	5.83e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2—malignant glioma	9.27e-06	5.83e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MDM2—malignant glioma	9.27e-06	5.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—STAT3—malignant glioma	9.25e-06	5.82e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—STAT3—malignant glioma	9.25e-06	5.82e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MYC—malignant glioma	9.24e-06	5.81e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RAF1—malignant glioma	9.23e-06	5.8e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	9.23e-06	5.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	9.21e-06	5.79e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AKT1—malignant glioma	9.2e-06	5.78e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	9.16e-06	5.76e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	9.14e-06	5.74e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	9.14e-06	5.74e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2—malignant glioma	9.13e-06	5.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	9.11e-06	5.73e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	9.11e-06	5.73e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AKT1—malignant glioma	9.1e-06	5.72e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—KRAS—malignant glioma	9.09e-06	5.71e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	9.07e-06	5.7e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—malignant glioma	9.07e-06	5.7e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	9.04e-06	5.68e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—malignant glioma	9.04e-06	5.68e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—malignant glioma	9.02e-06	5.67e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PTEN—malignant glioma	9.02e-06	5.67e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	9.02e-06	5.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	9.01e-06	5.66e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PTEN—malignant glioma	8.97e-06	5.64e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	8.95e-06	5.62e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—KRAS—malignant glioma	8.94e-06	5.62e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CG—malignant glioma	8.85e-06	5.56e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	8.83e-06	5.55e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL8—malignant glioma	8.8e-06	5.53e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	8.8e-06	5.53e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	8.78e-06	5.52e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	8.75e-06	5.5e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	8.73e-06	5.48e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—malignant glioma	8.71e-06	5.48e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	8.66e-06	5.44e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	8.64e-06	5.43e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—malignant glioma	8.6e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—malignant glioma	8.6e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PIK3CA—malignant glioma	8.59e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	8.59e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PIK3CA—malignant glioma	8.58e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PPARG—malignant glioma	8.54e-06	5.37e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—KRAS—malignant glioma	8.54e-06	5.37e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	8.53e-06	5.36e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—malignant glioma	8.52e-06	5.36e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—malignant glioma	8.52e-06	5.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	8.51e-06	5.35e-05	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	8.51e-06	5.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	8.48e-06	5.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTEN—malignant glioma	8.48e-06	5.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	8.46e-06	5.32e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	8.44e-06	5.3e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—malignant glioma	8.43e-06	5.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	8.43e-06	5.3e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—malignant glioma	8.43e-06	5.3e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—malignant glioma	8.41e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	8.41e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—malignant glioma	8.41e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	8.4e-06	5.28e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	8.38e-06	5.27e-05	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	8.37e-06	5.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	8.35e-06	5.25e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	8.35e-06	5.25e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—malignant glioma	8.31e-06	5.23e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	8.31e-06	5.22e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—malignant glioma	8.3e-06	5.22e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—malignant glioma	8.29e-06	5.21e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—malignant glioma	8.28e-06	5.2e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—malignant glioma	8.25e-06	5.19e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	8.22e-06	5.16e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	8.2e-06	5.15e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	8.19e-06	5.15e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	8.14e-06	5.12e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	8.12e-06	5.1e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—malignant glioma	8.11e-06	5.1e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	8.1e-06	5.09e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—malignant glioma	8.08e-06	5.08e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—malignant glioma	8.06e-06	5.07e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—malignant glioma	8.05e-06	5.06e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—malignant glioma	8.02e-06	5.04e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—malignant glioma	7.99e-06	5.02e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—malignant glioma	7.96e-06	5.01e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—malignant glioma	7.95e-06	5e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	7.94e-06	4.99e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—malignant glioma	7.94e-06	4.99e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—malignant glioma	7.92e-06	4.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	7.88e-06	4.95e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	7.88e-06	4.95e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	7.84e-06	4.93e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—malignant glioma	7.84e-06	4.92e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—malignant glioma	7.83e-06	4.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	7.8e-06	4.9e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—malignant glioma	7.79e-06	4.9e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CD—malignant glioma	7.78e-06	4.89e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAT—malignant glioma	7.78e-06	4.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—malignant glioma	7.76e-06	4.88e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAV1—malignant glioma	7.76e-06	4.88e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	7.76e-06	4.87e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—malignant glioma	7.72e-06	4.85e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	7.68e-06	4.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	7.67e-06	4.82e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—malignant glioma	7.66e-06	4.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	7.63e-06	4.79e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	7.61e-06	4.79e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	7.6e-06	4.78e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	7.59e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—malignant glioma	7.59e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	7.54e-06	4.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—malignant glioma	7.53e-06	4.73e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—malignant glioma	7.49e-06	4.71e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—malignant glioma	7.46e-06	4.69e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	7.44e-06	4.68e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.41e-06	4.66e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	7.4e-06	4.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—malignant glioma	7.36e-06	4.63e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NCOR1—malignant glioma	7.34e-06	4.62e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—malignant glioma	7.33e-06	4.61e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	7.3e-06	4.59e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	7.3e-06	4.59e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—malignant glioma	7.29e-06	4.58e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—malignant glioma	7.25e-06	4.56e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—malignant glioma	7.24e-06	4.55e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	7.17e-06	4.51e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—malignant glioma	7.16e-06	4.5e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—malignant glioma	7.15e-06	4.49e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—malignant glioma	7.14e-06	4.49e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	7.13e-06	4.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	7.09e-06	4.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	7.09e-06	4.45e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—malignant glioma	7.08e-06	4.45e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CG—malignant glioma	7.07e-06	4.44e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—malignant glioma	7.06e-06	4.44e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—malignant glioma	7.06e-06	4.44e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	7.04e-06	4.42e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—malignant glioma	7.02e-06	4.41e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—malignant glioma	7.01e-06	4.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	6.98e-06	4.39e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—malignant glioma	6.97e-06	4.38e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—malignant glioma	6.97e-06	4.38e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—malignant glioma	6.92e-06	4.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	6.91e-06	4.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	6.89e-06	4.33e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—malignant glioma	6.89e-06	4.33e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—malignant glioma	6.82e-06	4.29e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	6.82e-06	4.29e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARG—malignant glioma	6.82e-06	4.29e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CB—malignant glioma	6.78e-06	4.26e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—malignant glioma	6.72e-06	4.22e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—malignant glioma	6.71e-06	4.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	6.7e-06	4.21e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	6.65e-06	4.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	6.59e-06	4.14e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	6.59e-06	4.14e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—malignant glioma	6.58e-06	4.14e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—malignant glioma	6.47e-06	4.07e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—malignant glioma	6.44e-06	4.04e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—malignant glioma	6.43e-06	4.04e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—malignant glioma	6.41e-06	4.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	6.4e-06	4.02e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—malignant glioma	6.38e-06	4.01e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	6.36e-06	4e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—malignant glioma	6.34e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	6.34e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—malignant glioma	6.33e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	6.33e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CD—malignant glioma	6.21e-06	3.9e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	6.2e-06	3.9e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	6.16e-06	3.87e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—malignant glioma	6.15e-06	3.87e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—malignant glioma	6.12e-06	3.85e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—malignant glioma	6.08e-06	3.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	6.06e-06	3.81e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—malignant glioma	6.04e-06	3.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—malignant glioma	6.01e-06	3.78e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAV1—malignant glioma	5.99e-06	3.76e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—malignant glioma	5.98e-06	3.76e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—malignant glioma	5.98e-06	3.76e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	5.96e-06	3.75e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—malignant glioma	5.96e-06	3.75e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—malignant glioma	5.96e-06	3.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—malignant glioma	5.89e-06	3.7e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—malignant glioma	5.86e-06	3.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—malignant glioma	5.86e-06	3.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	5.86e-06	3.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	5.76e-06	3.62e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	5.59e-06	3.51e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	5.5e-06	3.45e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.45e-06	3.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	5.44e-06	3.42e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—malignant glioma	5.43e-06	3.41e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CB—malignant glioma	5.41e-06	3.4e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—malignant glioma	5.4e-06	3.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	5.38e-06	3.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	5.38e-06	3.38e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—malignant glioma	5.37e-06	3.37e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—malignant glioma	5.32e-06	3.34e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARG—malignant glioma	5.26e-06	3.31e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—malignant glioma	5.21e-06	3.27e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—malignant glioma	5.2e-06	3.27e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—malignant glioma	5.17e-06	3.25e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	5.03e-06	3.16e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	5e-06	3.14e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	4.95e-06	3.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—malignant glioma	4.88e-06	3.07e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—malignant glioma	4.84e-06	3.04e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.79e-06	3.01e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—malignant glioma	4.68e-06	2.94e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—malignant glioma	4.56e-06	2.87e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—malignant glioma	4.49e-06	2.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	4.4e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.18e-06	2.63e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—malignant glioma	4.14e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—malignant glioma	4.13e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	4.08e-06	2.57e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—malignant glioma	3.61e-06	2.27e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—malignant glioma	3.38e-06	2.12e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—malignant glioma	3.3e-06	2.07e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—malignant glioma	2.7e-06	1.69e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.55e-06	1.6e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—malignant glioma	2.08e-06	1.31e-05	CbGpPWpGaD
